Catalyst Pharmaceuticals
CPRX
#3959
Rank
S$3.91 B
Marketcap
S$31.84
Share price
0.24%
Change (1 day)
-0.95%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Cash on Hand

Cash on Hand as of December 2025 : S$0.90 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company has S$0.90 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalyst Pharmaceuticals - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$0.91 B29.43%
2024-12-31S$0.70 B287.01%
2023-12-31S$0.18 B-54.56%
2022-12-31S$0.40 B54.71%
2021-12-31S$0.25 B39.33%
2020-12-31S$0.18 B45.63%
2019-12-31S$0.12 B74.41%
2018-12-31S$73.06 M-34.98%
2017-12-31S$0.11 B92.15%
2016-12-31S$58.47 M-29.2%
2015-12-31S$82.6 M59.17%
2014-12-31S$51.89 M72.75%
2013-12-31S$30.04 M59.34%
2012-12-31S$18.85 M141.47%
2011-12-31S$7.8 M10.71%
2010-12-31S$7.05 M-35.42%
2009-12-31S$10.92 M-35.1%
2008-12-31S$16.82 M-26.66%
2007-12-31S$22.94 M-26.78%
2006-12-31S$31.33 M2340.53%
2005-12-31S$1.28 M327.93%
2004-12-31S$0.3 M
2002-12-31S$0.18 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$25.78 B 2,734.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$17.44 B 1,817.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$11.46 B 1,160.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$1.20 B 32.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$12.01 M-98.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.00 B 120.06%๐Ÿ‡บ๐Ÿ‡ธ USA